title: Morphological evidence for uncontrolled proteolytic activity during the ovulatory process in indomethacin-treated rats.
abstract: The ovulatory process in cyclic rats was studied after prostanoid synthesis was blocked using indomethacin. Animals were injected at 12:00 h in pro-oestrus with 1.0 mg indomethacin or vehicle (olive oil) and killed at 18:30 h in pro-oestrus, at 02:00, 09:00 and 19:00 h in oestrus and at 09:00 h in metoestrus. Additional rats injected with 0.5 or 4.0 mg indomethacin were killed at 09:00 h in oestrus. No differences in either morphology or serum LH concentrations were found between vehicle or indomethacin-treated rats at 18:30 h in pro-oestrus. However, from 02:00 h in oestrus onward, the process of follicle rupture was altered considerably in indomethacin-treated rats, irrespective of the dose. Early vascular changes, observed in control rats at the apex of the follicle, were absent in indomethacin-treated rats. In some follicles, disruption of the theca layers, invasion of the perifollicular tissue by granulosa cells and follicular fluid, and release of the oocyte to the ovarian interstitium were observed at 02:00 h in oestrus. A small number of follicles ruptured at the ovarian surface. Furthermore, invasion of interstitial tissue, rupture of blood vessel walls, production of emboli of granulosa cells and follicular fluid, and inflammatory reactions were observed in oestrus and metoestrus. The results of the present study demonstrate uncontrolled proteolytic activity, and indicate that abnormal follicle rupture (but not inhibition of follicle rupture) is responsible for ovulation failure in indomethacin-treated rats.
authors: Department of Cell Biology, Physiology and Immunology, School of Medicine, University of Cordoba, Spain. fi1begac@uco.es
authors: F
authors: F
authors: Gaytán
authors: E
authors: E
authors: Tarradas
authors: C
authors: C
authors: Morales
authors: C
authors: C
authors: Bellido
authors: J Eugenio
authors: JE
authors: Sánchez-Criado
mesh_terms: D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D005260:Female; D007213:Indomethacin / Q000494:pharmacology*; D007986:Luteinizing Hormone / Q000097:blood; D009865:Oocytes / Q000166:cytology; D006080:Ovarian Follicle / Q000166:cytology* / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects*; D011359:Proestrus; D051381:Rats; D017208:Rats, Wistar
chemical_list: D016861:Cyclooxygenase Inhibitors; D007986:Luteinizing Hormone; D007213:Indomethacin